Pfizer-BioNTech Expects to Seek Approval for Vaccine for Younger Pediatric Population

pfizer biontech expects to seek approval for vaccine for younger pediatric population

Sumary of Pfizer-BioNTech Expects to Seek Approval for Vaccine for Younger Pediatric Population:

  • BioNTech CEO Ugur Sahin and CMO Ozlem Türeci, MD told a German news site they expect to seek approval for the Pfizer-BioNTech COVID-19 vaccine, BNT162b2 (Comirnaty) for the 5 to 11 year old population soon, and potentially could see the first doses of the vaccine become available in Europe by mid-October.
  • “In the coming weeks we will present the results of our study on the 5 to 11 year olds worldwide to the authorities and apply for approval of the vaccine for this age group, including here in Europe,” Türeci told SPIEGEL.
  • “The Pfizer-BioNTech vaccine received full Food and Drug Administration (FDA) approval in August, and they submitted their application for the booster dose to the American federal agency.

Want to know more click here go to source.

From -

Close

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close